Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI:10.1039/D0AN02286A

Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A

A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus

Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A

Recent advances in antibiotic resistance diagnosis using SERS: focus on the “ Big 5 ” challenges - Analyst (RSC Publishing) DOI:10.1039/D2AN00703G

PDF] Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.

Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review

From Point-of-Care Testing to eHealth Diagnostic Devices (eDiagnostics)

Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic

PDF] Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.

From Point-of-Care Testing to eHealth Diagnostic Devices (eDiagnostics)

Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A